Delivery Order SPE2DB22D2007-SPE2DB25FJ1AA
- Not listed
- The Defense Logistics Agency awarded a $43,110.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, with final delivery required by July 15, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded a $8,170 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on April 21, 2025, with an ultimate completion date of April 22, 2025. This non-competitive delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The pharmaceutical product will be performed at the contractor's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL pharmaceutical product. This $3,280.55 firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with a completion date of June 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $17,422.25 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used in treating inflammatory conditions. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 4, 2025, and performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is issued under a larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $5,543.70 to AmerisourceBergen Drug Corp for the supply of Humira Pen 40 mg/0.8 mls, a pharmaceutical product used to treat inflammatory conditions. This competitively awarded, firm fixed-price contract was issued on July 22, 2025, with an ultimate completion date of July 23, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $14,765.41 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL pharmaceutical products. This is a firm fixed price, non-set-aside contract with a completion date of August 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $32,686.99 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL on June 20, 2025, with an ultimate completion date of June 23, 2025. This delivery order represents a firm fixed price, competitively awarded contract with no set-aside designation. The award is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for HUMIRA(CF) Pen 40 MG/0.4 MLS on June 17, 2025, with a ceiling value of $3,095.26. This is a firm fixed-price delivery order with no set-aside designation, reflecting AmerisourceBergen's capability to compete in open federal procurement. The drug will be delivered to the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of June 18, 2025. This award represents a routine...
- The Defense Logistics Agency awarded a $3,776.50 firm fixed price delivery order to AmerisourceBergen Drug Corp on April 29, 2025, for the supply of HUMIRA Pen 40 mg/0.8 mls, a pharmaceutical product used in the treatment of autoimmune conditions. This non-set-aside competitive award is scheduled for completion by April 30, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,888.25 delivery order contract to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, with an ultimate completion date of August 5, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ1AADelivery Order
The Defense Logistics Agency awarded a $56,740.58 delivery order to AmerisourceBergen Drug Corp on April 25, 2025, for the supply of Humira (CF) Pen 40 mg/0.4 mL, with performance expected to conclude by April 28, 2025. This firm fixed-price, non-set-aside contract will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.9 million and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies a broad range of pharmaceutical products and medical supplies to federal military and veteran healthcare systems through competitive awards. The company's demonstrated capability to meet federal procurement requirements is evidenced by its extensive portfolio of delivery orders covering diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, and specialized medical supplies. This contract award reflects the ongoing reliance on AmerisourceBergen's pharmaceutical distribution network to support Defense Health Agency operations and other government healthcare systems through the DLA's procurement mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $56.7k | 4/25/25 |